PMID- 35888595 OWN - NLM STAT- MEDLINE DCOM- 20220728 LR - 20230308 IS - 1648-9144 (Electronic) IS - 1010-660X (Print) IS - 1010-660X (Linking) VI - 58 IP - 7 DP - 2022 Jun 30 TI - TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m2: A Hyperglycemic Clamp Validated Study. LID - 10.3390/medicina58070876 [doi] LID - 876 AB - Background and objectives: Chinese type 2 diabetes mellitus (T2DM) patients are characterized by a low body mass index (BMI), and significant insulin resistance (IR). The triglyceride glucose (TyG) index has not been studied as a means of assessing IR in Chinese T2DM patients with a BMI < 35 kg/m2. Materials and Methods: An open-label cross-sectional study recruited 102 Chinese T2DM patients with a BMI < 35 kg/m2. The hyper-insulinemic euglycemic clamp, homeostatic model assessment of IR (HOMA-IR), and TyG index were used to determine the level of IR. Based on Pearson's correlations, glucose disposal rate (GDR), TyG index, and HOMA-IR were analyzed. HOMA-IR and TyG index for IR were evaluated using multiple linear regression and multivariate logistic regression analyses. On the basis of the receiver operating characteristic (ROC) curve, the sensitivity, specificity, and optimal cut-off value of HOMA-IR and the TyG index were determined. Results: The mean values of GDR, HOMA-IR, and TyG index were 4.25 +/- 1.81, 8.05 +/- 7.98, and 8.12 +/- 0.86 mg/kg/min, respectively. Pearson's correlation coefficient was -0.418 between GDR and TyG index and -0.324 between GDR and HOMA-IR. ROC curve analysis showed that, among both sexes, the TyG index was a better discriminator of IR than HOMA-IR. The area under the ROC curve (AUC) of the TyG index (0.785, 0.691-0.879) was higher than that of HOMA-IR (0.73, 0.588-0.873) in all genders. The optimal cut-off values of the TyG index and HOMA-IR were 7.99 and 3.39, respectively. Conclusions: The TyG index showed more effectiveness in identifying IR in Chinese T2DM patients with a BMI < 35 kg/m2 compared to HOMA-IR. FAU - Luo, Ping AU - Luo P AUID- ORCID: 0000-0003-4728-2415 AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Cao, Yaoquan AU - Cao Y AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Li, Pengzhou AU - Li P AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Li, Weizheng AU - Li W AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Song, Zhi AU - Song Z AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Fu, Zhibing AU - Fu Z AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Zhou, Hui AU - Zhou H AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Yi, Xianhao AU - Yi X AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Zhu, Liyong AU - Zhu L AUID- ORCID: 0000-0002-4666-8458 AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. FAU - Zhu, Shaihong AU - Zhu S AUID- ORCID: 0000-0001-6209-3132 AD - Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. LA - eng GR - YX202102/Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University/ PT - Journal Article DEP - 20220630 PL - Switzerland TA - Medicina (Kaunas) JT - Medicina (Kaunas, Lithuania) JID - 9425208 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 0 (Triglycerides) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Biomarkers MH - Blood Glucose/analysis MH - Body Mass Index MH - China MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/complications MH - Female MH - Glucose MH - Humans MH - *Insulin Resistance MH - Male MH - Triglycerides PMC - PMC9325243 OTO - NOTNLM OT - HOMA-IR OT - TyG index OT - hyper-insulinemic euglycemic clamp OT - insulin resistance OT - type 2 diabetes mellitus COIS- The authors declare no conflict of interest. EDAT- 2022/07/28 06:00 MHDA- 2022/07/29 06:00 PMCR- 2022/06/30 CRDT- 2022/07/27 01:30 PHST- 2022/04/16 00:00 [received] PHST- 2022/05/30 00:00 [revised] PHST- 2022/06/25 00:00 [accepted] PHST- 2022/07/27 01:30 [entrez] PHST- 2022/07/28 06:00 [pubmed] PHST- 2022/07/29 06:00 [medline] PHST- 2022/06/30 00:00 [pmc-release] AID - medicina58070876 [pii] AID - medicina-58-00876 [pii] AID - 10.3390/medicina58070876 [doi] PST - epublish SO - Medicina (Kaunas). 2022 Jun 30;58(7):876. doi: 10.3390/medicina58070876.